Literature DB >> 18478040

Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.

Mylène Béri-Dexheimer1, Véronique Latger-Cannard, Christophe Philippe, Céline Bonnet, Pascal Chambon, Virginie Roth, Marie-José Grégoire, Pierre Bordigoni, Thomas Lecompte, Bruno Leheup, Philippe Jonveaux.   

Abstract

Germline RUNX1 mutations result in a rare autosomal dominant condition characterized by qualitative and quantitative platelet defects and predisposition to the development of myeloid malignancies (familial platelet disorder with propensity to acute myeloid leukaemia, FPD/AML). Only 13 pedigrees have previously been described so far. We report on two novel germline RUNX1 mutations: (1) an out-of-frame 8 bp heterozygous deletion (c.442_449del) in an FPD/AML pedigree and (2) a de novo 3.5 Mb deletion in the 21q22.11.21q22.12 region encompassing the RUNX1 gene in a mentally retarded female patient with short stature and thrombocytopenia. Interestingly, a similar de novo submicroscopic deletion has been recently reported in the literature in a mentally retarded patient. Mental retardation is one of the most common disorders and primary causes of thrombocytopenia are rare. When occurring together, these features should prompt to test for 21q22 deletion for comprehensive genetic counselling and clinical management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478040     DOI: 10.1038/ejhg.2008.89

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  31 in total

1.  Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.

Authors:  I Antony-Debré; N Duployez; M Bucci; S Geffroy; J-B Micol; A Renneville; N Boissel; N Dhédin; D Réa; B Nelken; C Berthon; T Leblanc; M-J Mozziconacci; R Favier; P G Heller; O Abdel-Wahab; H Raslova; V Latger-Cannard; C Preudhomme
Journal:  Leukemia       Date:  2015-08-28       Impact factor: 11.528

2.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

3.  Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies.

Authors:  Tim Ripperger; Kiran Tawana; Christian Kratz; Brigitte Schlegelberger; Jude Fitzgibbon; Doris Steinemann
Journal:  Eur J Hum Genet       Date:  2016-01-27       Impact factor: 4.246

4.  Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A.

Authors:  R Oegema; A de Klein; A J Verkerk; R Schot; B Dumee; H Douben; B Eussen; L Dubbel; P J Poddighe; I van der Laar; W B Dobyns; P J van der Spek; M H Lequin; I F M de Coo; M-C Y de Wit; M W Wessels; G M S Mancini
Journal:  Mol Syndromol       Date:  2010-09-14

Review 5.  Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

Authors:  Daria V Babushok; Monica Bessler
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

Review 6.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

7.  Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype.

Authors:  A Sorrell; C Espenschied; W Wang; J Weitzel; S Chu; P Parker; S Saldivar; R Bhatia
Journal:  Int J Clin Med       Date:  2012-12-01

8.  Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

Authors:  Iléana Antony-Debré; Vladimir T Manchev; Nathalie Balayn; Dominique Bluteau; Cécile Tomowiak; Céline Legrand; Thierry Langlois; Olivia Bawa; Lucie Tosca; Gérard Tachdjian; Bruno Leheup; Najet Debili; Isabelle Plo; Jason A Mills; Deborah L French; Mitchell J Weiss; Eric Solary; Remi Favier; William Vainchenker; Hana Raslova
Journal:  Blood       Date:  2014-12-09       Impact factor: 22.113

Review 9.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

Review 10.  Genetics of familial forms of thrombocytopenia.

Authors:  Carlo L Balduini; Anna Savoia
Journal:  Hum Genet       Date:  2012-08-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.